Keywords: Intratympanic steroids, Meniere's disease, vertigo, hearing loss, inner ear, corticosteroid injection, balance disorder, tinnitus

What is Meniere's Disease?

Meniere's disease is a chronic inner ear disorder that causes episodes of vertigo (a spinning sensation), fluctuating hearing loss, tinnitus (ringing in the ear), and a feeling of fullness in the ear. The condition is believed to result from an abnormal buildup of endolymphatic fluid in the inner ear, called endolymphatic hydrops. These attacks can be debilitating and unpredictable, significantly impacting quality of life.

How Intratympanic Steroids Work

Intratympanic steroid therapy involves injecting a concentrated corticosteroid (such as dexamethasone or methylprednisolone) directly through the eardrum into the middle ear space. From there, the medication diffuses into the inner ear through the round window membrane. This targeted delivery achieves high concentrations of anti-inflammatory medicine at the source of the problem—the inner ear—while minimizing systemic side effects.

The corticosteroids reduce inflammation, stabilize blood vessels, and improve fluid regulation within the inner ear. This helps decrease the frequency and severity of vertigo attacks, may halt the progression of hearing loss, and can also alleviate tinnitus in some patients.

Procedure and Treatment Protocol

The procedure is typically performed in an otolaryngologist's office. The ear is cleaned, and a local anesthetic may be applied to numb the eardrum. Using a tiny needle, the physician injects the steroid through the eardrum. The patient is instructed to lie still with the treated ear facing upward for about 20 to 30 minutes to allow the medication to absorb.

Treatments are often given as a series of injections—for example, one injection per week for three to four weeks. The exact protocol depends on the patient's response and the physician's judgment. Some patients require booster injections months later if symptoms return.

Benefits and Evidence

• Vertigo control: Studies show that intratympanic steroids can significantly reduce the frequency and intensity of vertigo spells. Many patients experience a 70-80% reduction in attacks.
• Hearing preservation: The treatment may stabilize existing hearing loss and, in some cases, even lead to modest improvement in hearing thresholds.
• Reduced tinnitus: Some patients report decreased loudness and annoyance from tinnitus.
• Minimally invasive: It avoids the risks of general anesthesia and surgery (such as endolymphatic sac decompression or labyrinthectomy).

Risks and Side Effects

• Pain or discomfort during the injection (brief and usually tolerable).
• Dizziness or vertigo immediately after the injection (usually temporary).
• Eardrum perforation (almost always heals spontaneously within days or weeks).
• Infections (very rare with sterile technique).
• Hearing loss (rare, and usually related to the disease rather than the injection).

Who is a Good Candidate?

Candidates for intratympanic steroid therapy include patients with definite Meniere's disease who continue to have frequent or severe vertigo attacks despite first-line conservative management. It may also be offered to those who cannot tolerate systemic steroids or who wish to avoid surgery. The treatment is considered safe for most adults, though it is not recommended for patients with active middle ear infections or known allergy to the drug.

Conclusion

Intratympanic steroid injections offer a safe, effective, and targeted treatment for Meniere's disease—particularly for vertigo control. While it does not cure the underlying disorder, it can dramatically restore quality of life by reducing the unpredictability of attacks, stabilizing hearing, and lessening tinnitus. As with any medical treatment, a thorough evaluation by an ear specialist is essential to determine if this therapy is appropriate for your specific situation.